DSpace Collection: https://dspace.bsmu.edu.ua/handle/123456789/1197 2026-04-14T19:25:41Z Системні скелетні дисплазії: диференційна діагностика https://dspace.bsmu.edu.ua/handle/123456789/20718 Title: Системні скелетні дисплазії: диференційна діагностика Authors: Ластівка, І.В.; Анцупова, В.В.; Заярна, Л.П. 2021-01-01T00:00:00Z Вроджений нефротичний синдром: роль медично-генетичного консультування https://dspace.bsmu.edu.ua/handle/123456789/20713 Title: Вроджений нефротичний синдром: роль медично-генетичного консультування Authors: Ластівка, І.В.; Анцупова, В.В.; Заярна, Л.П. 2021-01-01T00:00:00Z Concentration of alpha-defensins in the blood plasma of children with Helicobacter pylori – associated peptic ulcer of the duodenum https://dspace.bsmu.edu.ua/handle/123456789/20701 Title: Concentration of alpha-defensins in the blood plasma of children with Helicobacter pylori – associated peptic ulcer of the duodenum Authors: Sorokman, Tamila V.; Moldovan, Pavlo M.; Sokolnyk, Iryna S.; Koliesnik, Dmytro I.; Popelyuk, Natalia O. Abstract: Various gastrointestinal and extragastric diseases are associated with H. pylori in children and adolescents, but the strongest testing and treatment guidelines are only for children and adolescents with peptic ulcer. The most promising developments now are the study of the antibacterial effect of endogenous antimicrobial peptides (AP), among which the most important are defenses 1-3 (human neutrophil peptides, HNPs 1-3). Objective. To investigate the concentration of HNPs 1-3 in children with H. pylori-associated peptic ulcer of the duodenum (DU). 2022-01-01T00:00:00Z Improvement of eradication therapy in children with duodenal ulcer associated with Helicobacter pylori https://dspace.bsmu.edu.ua/handle/123456789/20700 Title: Improvement of eradication therapy in children with duodenal ulcer associated with Helicobacter pylori Authors: Sorokman, Tamila V.; Sokolnyk, Snizhana V.; Moldovan, Pavlo M.; Chernei, Nadiia Ya.; Ostapchuk, Valentuna G. Abstract: The aim: To evaluate the efficacy of the drug VitD children with H.pylori-associated duodenal ulcer. Conclusions: Due to the reduced level of serum VitD in children with H. pylori-associated DU, it is advisable to include in the treatment regimen the adjuvant component of AHBT in the form of VitD. Predictors of effective eradication of H. pylori are CagA (+) strain of H. pylori, duration of infection and VitD level. 2022-01-01T00:00:00Z